-
公开(公告)号:US20120088765A1
公开(公告)日:2012-04-12
申请号:US13266681
申请日:2010-04-28
申请人: Toshiaki Suzuki , Hideki Satoh , Toshiyuki Matsuno , Kenichi Saitoh , Soichi Ohta , Manami Masuda , Shinichi Yaguchi , Ichiro Koshimizu , Yuriko Watanabe , Yoshie Minowa , Masayuki Takahashi , Tomoyoshi Kayou
发明人: Toshiaki Suzuki , Hideki Satoh , Toshiyuki Matsuno , Kenichi Saitoh , Soichi Ohta , Manami Masuda , Shinichi Yaguchi , Ichiro Koshimizu , Yuriko Watanabe , Yoshie Minowa , Masayuki Takahashi , Tomoyoshi Kayou
IPC分类号: A61K31/5377 , A61P35/00 , C07D473/24 , C07D413/14 , A61K31/52
CPC分类号: A61K31/52 , A61K31/5377 , C07D473/24
摘要: Disclosed are: a novel purine derivative, a composition thereof, a method for treating tumor using the purine derivative, and an antitumor agent using the purine derivative. Specifically disclosed is a compound represented by formula (I), or a pharmaceutically acceptable salt, solvate or hydrate thereof, or a prodrug thereof.
摘要翻译: 公开了一种新型嘌呤衍生物,其组合物,使用嘌呤衍生物治疗肿瘤的方法,以及使用嘌呤衍生物的抗肿瘤剂。 具体公开的是由式(I)表示的化合物或其药学上可接受的盐,溶剂合物或水合物或其前药。
-
公开(公告)号:US09132130B2
公开(公告)日:2015-09-15
申请号:US13266681
申请日:2010-04-28
申请人: Toshiaki Suzuki , Hideki Satoh , Toshiyuki Matsuno , Kenichi Saitoh , Soichi Ohta , Manami Masuda , Shinichi Yaguchi , Ichiro Koshimizu , Yuriko Watanabe , Yoshie Minowa , Masayuki Takahashi , Tomoyoshi Kayou
发明人: Toshiaki Suzuki , Hideki Satoh , Toshiyuki Matsuno , Kenichi Saitoh , Soichi Ohta , Manami Masuda , Shinichi Yaguchi , Ichiro Koshimizu , Yuriko Watanabe , Yoshie Minowa , Masayuki Takahashi , Tomoyoshi Kayou
IPC分类号: A61K31/52 , C07D473/36 , C07D487/12 , C07D473/24 , A61K31/5377
CPC分类号: A61K31/52 , A61K31/5377 , C07D473/24
摘要: Disclosed are: a novel purine derivative, a composition thereof, a method for treating tumor using the purine derivative, and an antitumor agent using the purine derivative. Specifically disclosed is a compound represented by formula (I), or a pharmaceutically acceptable salt, solvate or hydrate thereof, or a prodrug thereof.
摘要翻译: 公开了一种新型嘌呤衍生物,其组合物,使用嘌呤衍生物治疗肿瘤的方法,以及使用嘌呤衍生物的抗肿瘤剂。 具体公开的是由式(I)表示的化合物或其药学上可接受的盐,溶剂合物或水合物或其前药。
-